Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

Bone Therapeutics S.A.. (3/7/18). "Press Release: Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies.

Organisations Organisation Bone Therapeutics S.A. (Euronext Brussels + Paris: BOTHE)
  Group Bone Therapeutics (Group)
  Organisation 2 NewCap. – Investor Relations & Financial Communications
Products Product ALLOB® allogeneic bone cell product
  Product 2 investment banking
Persons Person Liénard, Thomas (Bone Therapeutics 201610– Interim CEO joined 201511– as CBO before Lundbeck + Lilly + McKinsey)
  Person 2 Laurent, Pierre (NewCap. 201404 CEO + Owner)
     


   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Bone Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x300px




» top